23andMe Holding Co (ME)
3.00
-0.82
(-21.47%)
USD |
NASDAQ |
Nov 15, 16:00
3.02
+0.02
(+0.67%)
After-Hours: 20:00
23andMe Revenue (Annual): 219.64M for March 31, 2024
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
March 31, 2024 | 219.64M |
March 31, 2023 | 299.49M |
March 31, 2022 | 271.89M |
Date | Value |
---|---|
March 31, 2021 | 243.92M |
March 31, 2020 | 305.46M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
219.64M
Minimum
2024
305.46M
Maximum
2020
268.08M
Average
271.89M
Median
2022
Revenue (Annual) Benchmarks
RadNet Inc | 1.617B |
iSpecimen Inc | 9.928M |
Natera Inc | 1.083B |
Progyny Inc | 1.089B |
Delcath Systems Inc | 2.065M |